原发性胆汁性胆管炎患者的自身反应性单克隆抗体识别环境异生物质
研究从原发性胆汁性胆管炎患者外周血浆母细胞构建104株重组单克隆抗体,发现32株与天然PDC-E2反应,其中12株交叉识别PDC-E2与化学异生物质2-辛炔酸和6,8-双(乙酰硫基)辛酸,交叉反应抗体体细胞超突变频率较低,并可识别硫辛酸,提示化学修饰的硫辛酸或硫辛酸本身通过分子模拟成为疾病起始靶点。
要点
- 从原发性胆汁性胆管炎患者浆母细胞构建104株重组单克隆抗体。
- 32株与天然PDC-E2反应,其中20株特异性识别PDC-E2,12株交叉识别PDC-E2与2-辛炔酸和6,8-双(乙酰硫基)辛酸。
- 交叉反应抗体互补决定区替换性体细胞超突变频率较低,提示亲和成熟水平较低。
核心结论
- 数据反映化学修饰的硫辛酸或硫辛酸本身通过分子模拟是导致原发性胆汁性胆管炎发展的初始靶点。
研究设计与样本
- 基于原发性胆汁性胆管炎患者单个浆母细胞的配对重链和轻链可变区,生成104株重组单克隆抗体。
主要发现
- 104株重组单克隆抗体中鉴定出32株与天然PDC-E2反应,包括20株特异性针对PDC-E2和12株与PDC-E2及2-辛炔酸和6,8-双(乙酰硫基)辛酸均交叉反应。
- 交叉反应单克隆抗体互补决定区的替换性体细胞超突变频率低于仅识别PDC-E2的单克隆抗体或针对无关抗原的单克隆抗体,提示亲和成熟水平较低。
- 将一株交叉反应单克隆抗体的高突变重链基因回复为胚系序列后,PDC-E2反应性大幅降低,而异生物质反应性保留。
- 交叉反应单克隆抗体也识别硫辛酸,一种与PDC-E2共价结合的线粒体脂肪酸。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: A major problem in autoimmunity has been identification of the earliest events that lead to breach of tolerance. Although there have been major advances in dissecting effector pathways and the multilineage immune responses to mitochondrial self-antigens in primary biliary cholangitis, the critical links between environmental factors and tolerance remain elusive. We hypothesized that environmental xenobiotic modification of the E2 subunit of the pyruvate dehydrogenase (PDC-E2) inner lipoyl domain can lead to loss of tolerance to genetically susceptible hosts. Previously we demonstrated that serum anti-PDC-E2 autoantibodies cross-react with the chemical xenobiotics 2-octynoic acid and 6,8-bis (acetylthio) octanoic acid and further that there is a high frequency of PDC-E2-specific peripheral plasmablasts. Herein we generated 104 recombinant monoclonal antibodies (mAbs) based on paired heavy-chain and light-chain variable regions of individual plasmablasts derived from primary biliary cholangitis patients. We identified 32 mAbs reactive with native PDC-E2, including 20 specific for PDC-E2 and 12 cross-reactive with both PDC-E2 and 2-octynoic acid and 6,8-bis (acetylthio) octanoic acid. A lower frequency of replacement somatic hypermutations, indicating a lower level of affinity maturation, was observed in the complementarity-determining regions of the cross-reactive mAbs in comparison to mAbs exclusively recognizing PDC-E2 or those for irrelevant antigens. In particular, when the highly mutated heavy-chain gene of a cross-reactive mAb was reverted to the germline sequence, the PDC-E2 reactivity was reduced dramatically, whereas the xenobiotic reactivity was retained. Importantly, cross-reactive mAbs also recognized lipoic acid, a mitochondrial fatty acid that is covalently bound to PDC-E2. CONCLUSION: Our data reflect that chemically modified lipoic acid or lipoic acid itself, through molecular mimicry, is the initial target that leads to the development of primary biliary cholangitis. (Hepatology 2017;66:885-895).
引用
- Tanaka T, Zhang W, Sun Y, et al. Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics. Hepatology. 2017. PMID: 28470667. doi:10.1002/hep.29245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。